CVRx, Inc. Common Stock
$3.02
$0.02 (+0.67%)
$2.92Day Range$3.13
Key Statistics
Market Cap
$80.46M
Shares Outstanding
26.6M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 30, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$2.99
Day High
$3.13
Day Low
$2.92
Volume
415.9K
VWAP
$3.01
Prev Close
$3.00
Transactions
--
Acc. Volume
--
About CVRx, Inc. Common Stock
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841223 employees9201 WEST BROADWAY AVENUE, MINNEAPOLIS, MN, 55445(763) 416-2850IPO Jun 30, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001235912
- Composite FIGI
- BBG001B56NX0
- Share Class FIGI
- BBG001TJ3M57
- Ticker Root
- CVRX
- SIC Code
- 3841
About CVRx, Inc. Common Stock (CVRX) Stock
CVRx, Inc. Common Stock (CVRX) closed the 2026-09-16 session at $3.02, up 0.67% versus the previous close (+0.02). The stock opened at $2.99 and traded between $2.92 and $3.13 during that session. Session trading volume was 416K shares. The volume-weighted average price (VWAP) is $3.01.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
CVRx, Inc. Common Stock has a market capitalization of $80.5 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. CVRX is listed on the XNAS exchange. The company employs approximately 223 people. CVRx, Inc. Common Stock is headquartered in MINNEAPOLIS, MN. The recorded listing date is 2021-06-30.
On this page you can find market CVRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.